Therapeutic evaluation of targeting Tau Tubulin kinase-1 in Alzheimer’s disease

Medicine & Life Sciences

1. tau-tubulin kinase 100%
2. Alzheimer Disease 51%
3. Antisense Oligonucleotides 29%
4. Entorhinal Cortex 18%
5. Brain 9%
6. Pathology 9%
7. human MAPT protein 8%
8. Therapeutics 8%
9. Phosphotransferases 7%
10. Tauopathies 6%
11. Prodromal Symptoms 6%
12. Organoids 6%
13. Hippocampal CA1 Region 6%
14. Frontotemporal Dementia 6%
15. Neurons 6%
16. Efficiency 5%
17. Preliminary Data 5%
18. Pyramidal Cells 5%